CLINICAL_TRIALS
trial_result
· 2019-07-10
Clinical Trial Update: Open Label Study of Long Term Evaluation Against LDL-C Trial [Phase 2]
Summary
Open-label Phase 2 trial evaluating long-term LDL-C reduction in hypercholesterolemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Amgen | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2019-07-10